• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Changing Landscape of Fabry Disease.

作者信息

Svarstad Einar, Marti Hans Peter

机构信息

Department of Medicine, Haukeland University Hospital, Bergen, Norway; and.

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

出版信息

Clin J Am Soc Nephrol. 2020 Apr 7;15(4):569-576. doi: 10.2215/CJN.09480819. Epub 2020 Mar 4.

DOI:10.2215/CJN.09480819
PMID:32132142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7133143/
Abstract
摘要

相似文献

1
The Changing Landscape of Fabry Disease.法布里病不断变化的形势
Clin J Am Soc Nephrol. 2020 Apr 7;15(4):569-576. doi: 10.2215/CJN.09480819. Epub 2020 Mar 4.
2
Genetics and Gene Therapy of Anderson-Fabry Disease.安德森-法布里病的遗传学和基因治疗。
Curr Gene Ther. 2018;18(2):96-106. doi: 10.2174/1566523218666180404161315.
3
Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study.基线左心室肥厚和肾功能下降对接受阿加糖酶α治疗的法布病患者心血管和肾脏结局的影响：一项法布病结局调查研究。
Clin Ther. 2020 Dec;42(12):2321-2330.e0. doi: 10.1016/j.clinthera.2020.10.007. Epub 2020 Nov 17.
4
[Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].[法布里病的肾脏受累：诊断、随访及酶替代治疗]
G Ital Nefrol. 2009 Sep-Oct;26(5):577-84.
5
Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.法布里病的酶替代疗法：最新进展与临床应用
J Nephrol. 2004 May-Jun;17(3):354-63.
6
Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.法布里病心肌病酶替代疗法的矛盾反应
Circ Cardiovasc Imaging. 2016 Aug;9(8). doi: 10.1161/CIRCIMAGING.116.005078.
7
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.接受肾脏替代治疗的法布里病患者的阿加糖酶治疗：意大利的一项全国性研究。
Nephrol Dial Transplant. 2008 May;23(5):1628-35. doi: 10.1093/ndt/gfm813. Epub 2007 Dec 5.
8
Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?法布瑞氏肾病：综述——我们如何优化法布瑞氏肾病的管理？
BMC Nephrol. 2014 May 6;15:72. doi: 10.1186/1471-2369-15-72.
9
Stroke and Chronic Kidney Disease in Fabry Disease.法布瑞氏病中的中风和慢性肾脏病。
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105423. doi: 10.1016/j.jstrokecerebrovasdis.2020.105423. Epub 2020 Nov 5.
10
Renal complications of Fabry disease.法布瑞氏病的肾脏并发症。
Curr Pharm Des. 2013;19(33):6046-50. doi: 10.2174/13816128113199990346.

引用本文的文献

1
Ocular and confocal manifestations of Mainland Chinese with Fabry disease: a cross-sectional controlled study.中国大陆法布里病患者的眼部和共焦表现：一项横断面对照研究。
Orphanet J Rare Dis. 2025 Aug 10;20(1):417. doi: 10.1186/s13023-025-03940-9.
2
confocal microscopic study of cornea verticillata and limbus deposits in patients with Fabry disease.法布里病患者角膜涡状浑浊和角膜缘沉积物的共聚焦显微镜研究
Front Med (Lausanne). 2025 Feb 5;12:1541510. doi: 10.3389/fmed.2025.1541510. eCollection 2025.
3
Unexpected Hypotension in a Female Patient with Fabry Disease: Switching from Agalsidase α to β after Long-term ERT.法布里病女性患者出现意外低血压：长期酶替代治疗后从α-半乳糖苷酶转换为β-半乳糖苷酶
Intern Med. 2025 Aug 1;64(15):2369-2374. doi: 10.2169/internalmedicine.4685-24. Epub 2025 Feb 8.
4
Health State Utility Values in Fabry Disease: Insights from the Pegunigalsidase Alfa Clinical Trials.法布里病的健康状态效用值：来自聚乙二醇化α-半乳糖苷酶临床试验的见解。
Adv Ther. 2025 Mar;42(3):1421-1434. doi: 10.1007/s12325-024-03095-2. Epub 2025 Jan 23.
5
Fabry disease: a rare disorder calling for personalized medicine.法布瑞氏病：一种罕见的需要个体化医疗的疾病。
Int Urol Nephrol. 2024 Oct;56(10):3161-3172. doi: 10.1007/s11255-024-04042-4. Epub 2024 Apr 13.
6
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations.女性法布里病：遗传基础、可用生物标志物和临床表现。
Genes (Basel). 2023 Dec 26;15(1):37. doi: 10.3390/genes15010037.
7
Outcomes and management of kidney transplant recipients with Fabry disease: a review.肾移植受者法布里病的结局和治疗：综述。
J Nephrol. 2024 Apr;37(3):561-571. doi: 10.1007/s40620-023-01853-z. Epub 2024 Jan 16.
8
Prevalence of Kidney and Urinary Tract Complications in Fabry Disease from 2000 to 2020: A Global Cohort Study Including 10,637 Patients.2000 年至 2020 年期间法布瑞病肾脏和泌尿道并发症的流行情况：一项纳入 10637 例患者的全球队列研究。
In Vivo. 2023 Nov-Dec;37(6):2609-2617. doi: 10.21873/invivo.13368.
9
Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla zebrafish model of Fabry disease.蛋白质组学分析揭示了 Fabry 病 gla 斑马鱼模型中 Gb3 非依赖性改变和线粒体功能障碍。
J Transl Med. 2023 Sep 5;21(1):591. doi: 10.1186/s12967-023-04475-y.
10
Gastrointestinal Manifestations and Low- Protocol in a Cohort of Fabry Disease Adult Patients.法布里病成年患者队列中的胃肠道表现和低方案。
Nutrients. 2023 Jan 28;15(3):658. doi: 10.3390/nu15030658.